A new visit to the center's opening: a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
Activities have resumed under the GPL/CT/2023 project – a study of the efficacy and safety of levosalbutamol /ipratropium bromide in patients with mild to moderate asthma.
Our center successfully completed a center qualification visit for a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
The visit of the opening of the center for the participation of patients in the clinical trial of the drug Broncho-munal® P, capsules, 3.5 mg in the treatment of pediatric patients with acute uncomplicated respiratory tract infections was successfully completed, the study was sponsored by Sandoz.
